Murari Kumar Jha

Translational bioengineering perspectives on biosensors and nanorobotics for cancer theranostics

The convergence of diagnostics and therapeutics, known as cancer theranostics, has become the backbone of 21st-century precision oncology. In the past decade, exponential progress in the engineering of nano-biosensors, nanorobotic actuation, and molecular biomarker profiling has allowed for the interrogation of tumors...